Answer to Question 1
B
Feedback:
Daclizumab is specific to interleukin-2 receptor sites on activated T lymphocytes; it reacts with those sites and blocks cellular response to allograft transplants. Alemtuzumab is an antibody specific for lymphocyte receptor sites used to treat chronic lymphocytic leukemia patients who have been treated with alkylating agents and have been failed by fludarabine therapy. Erlotinib is effective against specific malignant receptor sites. Omalizumab is an antibody to immunoglobulin E, an important factor in allergic reactions.
Answer to Question 2
A
Feedback:
The next phase, called the S phase, involves the actual synthesis of DNA, which is an energy-consuming activity. The cell remains in this phase until the amount of cellular DNA has doubled. The G0 phase is considered the resting phase of the cell cycle. The M phase is when cell replication occurs. The G2 phase is when the cell produces all substances it needs to replicate.
NUrse
Nurses possess a wide variety of experiences which they take into each patient encounter.
Sharing patient information with colleagues is an important nursing role
Lab: Learn Orders in Class Insecta
Patient registration form.
Gingival enlargement in a patient taking nifedipine.